Contact Us
Drug Search Results
More Filters [+]

Ritobegron

Alternative Names: ritobegron, kuc-7483, kuc7483, kuc 7483
Latest Update: 2023-09-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ADRB3 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Boehringer Ingelheim
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ritobegron

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Overactive Bladder

Phase 1: Healthy Volunteers|Spinal Cord Injuries

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
NCT02256735

P1

Completed

Healthy Volunteers

2005-12-01

NCT02256722

P1

Completed

Healthy Volunteers

2005-11-01

2004-004590-28

P2

Completed

Overactive Bladder

2005-06-30

NCT02259751

P1

Completed

Spinal Cord Injuries

2005-02-01

Recent News Events

Date

Type

Title

09/01/2023

PubMed

 Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density.

04/06/2022

PubMed

 Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions